OQS
DERM icon

Occudo Quantitative Strategies’s Journey Medical DERM Stock Holding History

Occudo Quantitative Strategies’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,913
Closed -$146K – 782
2025
Q4 		$146K Buy
18,913
+3,443
+22% +$27K 0.01% 625
2025
Q3 		$110K Buy
+15,470
New +$112K 0.01% 619

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Occudo Quantitative Strategies's DERM Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 18,913 shares — an estimated $146K sold.

Occudo Quantitative Strategies first reported a position in DERM in Q3 2025 and held it in 2 quarters. The position peaked at $146K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 18,913 Journey Medical shares in Q1 2026, an estimated $146K.
  • Occudo Quantitative Strategies first reported a position in Journey Medical in Q3 2025 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Journey Medical position peaked at $146K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.